Cosmos Health Inc.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more
Cosmos Health Inc. (COSM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.172x
Based on the latest financial reports, Cosmos Health Inc. (COSM) has a cash flow conversion efficiency ratio of -0.172x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.97 Million) by net assets ($23.13 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cosmos Health Inc. - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Cosmos Health Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cosmos Health Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cosmos Health Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chromocell Therapeutics Corporation
NYSE MKT:CHRO
|
0.069x |
|
JCBNext Berhad Bhd
KLSE:0058
|
0.008x |
|
Scandinavian Investment Group A/S
CO:SIG
|
0.032x |
|
artnet AG
PINK:ARTZF
|
0.708x |
|
Taiwan Advanced Nanotech Inc.
TWO:6797
|
-0.021x |
|
EAST STAR RES.PLC LS-01
F:5MM
|
N/A |
|
FORIS AG
F:FRS
|
-0.100x |
|
BP Plastics Holding Bhd
KLSE:5100
|
0.020x |
Annual Cash Flow Conversion Efficiency for Cosmos Health Inc. (2010–2024)
The table below shows the annual cash flow conversion efficiency of Cosmos Health Inc. from 2010 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $24.53 Million | $-7.72 Million | -0.315x | +27.49% |
| 2023-12-31 | $36.04 Million | $-15.64 Million | -0.434x | -15.69% |
| 2022-12-31 | $39.66 Million | $-14.87 Million | -0.375x | +76.86% |
| 2021-12-31 | $4.38 Million | $-7.10 Million | -1.621x | -158.63% |
| 2020-12-31 | $-4.16 Million | $-11.50 Million | 2.764x | +272.92% |
| 2019-12-31 | $-6.46 Million | $-4.79 Million | 0.741x | +58.10% |
| 2018-12-31 | $-3.32 Million | $-1.56 Million | 0.469x | -83.80% |
| 2017-12-31 | $-3.03 Million | $-8.76 Million | 2.893x | +138.52% |
| 2016-12-31 | $-1.75 Million | $-2.13 Million | 1.213x | +204.48% |
| 2015-12-31 | $-1.25 Million | $-497.09K | 0.398x | -66.58% |
| 2014-12-31 | $5.47 Million | $6.53 Million | 1.192x | +107.70% |
| 2013-12-31 | $-53.68K | $831.40K | -15.487x | -67992.51% |
| 2012-12-31 | $-1.36K | $31.00 | -0.023x | -100.12% |
| 2011-12-31 | $-4.76K | $-87.29K | 18.330x | +360.38% |
| 2010-12-31 | $-17.48K | $-69.60K | 3.982x | -- |